ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Editor's choice: Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know
Thursday, October 9, 2014
Submitted by
Source
Source Name: European Journal of Cardio-Thoracic Surgery
This paper presents an update on diagnostic and prognostic biomarkers in malignant pleural mesothelioma considering also recent molecular biologic achievements as microRNA and genomic sequencing.
Printer-friendly
